Eurycoma longifolia, a potential phytomedicine for the treatment of cancer: Evidence of p53-mediated apoptosis in cancerous cells
Background: Eurycoma longifolia is a well-documented herbal medicine that has gained widespread recognition due to its versatile pharmacological activities including anticancer, antimalarial, antimicrobial, antioxidant, aphrodisiac, anti-inflammatory, anxiolytic, anti-diabetic, antirheumatism and an...
Published in: | Current Drug Targets |
---|---|
Main Author: | Thu H.E.; Hussain Z.; Mohamed I.N.; Shuid A.N. |
Format: | Review |
Language: | English |
Published: |
Bentham Science Publishers B.V.
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045467661&doi=10.2174%2f1389450118666170718151913&partnerID=40&md5=c8124f16f24169d748b5a18b95c491b4 |
Similar Items
-
Eurycoma Longifolia as a potential adoptogen of male sexual health: a systematic review on clinical studies
by: Thu H.E.; Mohamed I.N.; Hussain Z.; Jayusman P.A.; Shuid A.N.
Published: (2017) -
Damnacanthal is a potent inducer of apoptosis with anticancer activity by stimulating p53 and p21 genes in MCF-7 breast cancer cells
by: Aziz M.Y.A.; Omar A.R.; Subramani T.; Yeap S.K.; Ho W.Y.; Ismail N.H.; Ahmad S.; Alitheen N.B.
Published: (2014) -
Recent advances in antibacterial, antiprotozoal and antifungal trends of eurycoma longifolia: A review of therapeutic implications and future prospects
by: Ei Thu H.; Hussain Z.; Mohamed I.N.; Shuid A.N.
Published: (2018) -
Exploring dynamic biomedical algorithm of Eurycoma longifolia Jack and its bioactive phytochemicals: A review of pharmacokinetic and pharmacodynamic implications and future prospects
by: Thu H.; Hussain Z.; Mohamed I.; Shuid A.
Published: (2018) -
Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
by: Zamanian M.; Qader Hamadneh L.A.; Veerakumarasivam A.; Abdul Rahman S.; Shohaimi S.; Rosli R.
Published: (2016)